Weekend Educational Session
No Way to Treat a Lady: Breast & Female Reproductive Organ Cancers
Back to Program-at-a-Glance
Session Topic: No Way to Treat a Lady: Breast & Female Reproductive Organ Cancers
Session Sub-Topic: No Way to Treat a Lady: Breast & Female Reproductive Organ Cancers
Weekend Course
ORGANIZERS: Reiko Woodhams, Daniel Margolis
| Saturday Parallel 1 Live Q&A | Saturday, 8 August 2020, 16:00 - 16:30 UTC | Moderators: Breast Cancer: Reiko Woodhams Female Reproductive Organ Cancers: Aki Kido |
Skill Level: Basic to Intermediate
Session Number: WE-10
Overview
This course will outline the basics of imaging, along with emerging and novel applications, for the following cancers:
- Breast
- Uterus/Endometrium
- Cervix
- Ovary/Fallopian Tube
Target Audience
Residents, clinical fellows, practicing radiologists, and scientists involved in cancer imaging.
Educational Objectives
As a result of attending this course, participants should be able to:
- Develop protocols for multi-parametric breast MRI;
- Apply diffusion-weighted imaging for breast cancer characterization and screening;
- Integrate breast MRI with additional modalities and diagnostic methods (e.g., genetic screening);
- Identify patients for whom MRI-guided procedures (e.g. biopsy) would be appropriate;
- Develop protocols for and interpret MRI for endometrial, cervical, and ovarian cancers;
- List uterine and cervical cancer stages using MRI features;
- Facilitate interactions with technologists to perform patient-optimized scanning, including scan planes and techniques;
- Evaluate response to treatment for cervical and other pelvic malignancies; and
- Recognize benign mimics of female pelvic malignancies.
| Breast Cancer | ||
| Conventional Breast MRI Techniques & Reporting
Mami Iima
This course describes the current status of breast MR imaging. The strengths and weaknesses of breast MRI and clinical indications are also discussed. The BI-RADS classification system designed to standardize breast imaging reporting consisting in a lexicon for standardized terminology for mammography, ultrasonography or MRI is introduced, as well as chapters on report organization and guidance chapters for use in daily practice.
|
||
| Breast Cancer Screening in the High-Risk Patient
Rebecca Rakow-Penner
|
||
| Breast MRI: Future Directions
Savannah Partridge
|
||
| Female Reproductive Organ Cancers | ||
 |
Endometrial Cancer & Other Uterine Malignancies
Yumiko Tanaka
Diagnosing local extension of the endometrial carcinoma with MR is crucial as myometrial and cervical stromal invasion are important prognostic factors. However, the utility of T2-weighted, contrast-enhanced, and diffusion-weighted images is controversial. In this lecture, oncologically essential facts and tips of the MR in diagnosing endometrial carcinoma will be presented. Leiomyosarcoma is the most common malignant mesenchymal tumor of the uterus; however, it is still difficult to differentiate it from uterine fibroids. We will provide MR findings of leiomyosarcoma comparing to those of histological variants of uterine fibroid and cutting edge technology in differentiating these two disease entities.
|
|
| Cervical Cancer
Nandita DeSouza
MRI is the fundamental imaging modality in the management pathway of cervical cancer. Its use is crucial for early diagnosis, for tumor staging, to provide prognostic information, to monitor the effects of treatment and to follow-up patients for detection of disease recurrence.
|
||
| Can We Predict Disease Better?
Carolyn Mountford
|
||
Watch the Video
Back to Top